NASDAQ:HRMY | Cash Flow Statement | Harmony Biosciences Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$75.43M
2026-03-31$32.49M$27.76M-$183.65M-$7.22M
2025-12-31$22.49M$126.15M$107,000.00-$17.63M-$3.02M
2025-09-30$50.87M
2025-06-30$39.78M
2025-03-31$45.56M$33.99M$128,000.00$2.36M-$352,000.00
2024-12-31$49.48M$75.56M$513,000.00-$7.19M-$2.74M
2024-09-30$46.09M
2024-06-30$11.59M
2024-03-31$38.33M$31.14M$5,000.00-$6.19M-$3.63M
2023-12-31$26.61M$76.67M$107,000.00-$36.07M$50M-$53.52M
2023-09-30$38.46M
2023-06-30$34.3M
2023-03-31$29.49M$42.56M-$1.79M$3.41M
2022-12-31$48.51M$26.68M$0.00-$46.9M$2.66M
2022-09-30$87.94M
2022-06-30$23.53M
2022-03-31$21.49M$28.85M$45,000.00-$40.05M$1.38M
2021-12-31$22.71M$37.53M$0.00$0.00$7.07M
2021-09-30-$9.62M
2021-06-30$14.12M
2021-03-31$7.39M$12.53M$4,000.00-$100M$12,000.00
2020-12-31-$208,000.00$10.05M$0.00-$2M$0.00-$1.16M
2020-09-30$1.91M
2020-06-30-$27,000.00
2020-03-31-$38.62M-$26.7M$73.76M
2019-12-31-$36.44M-$23.99M$36,000.00-$77.04M$24.21M
2019-09-30-$31.9M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$158.69M$348.2M$310,000.00-$39.65M-$9.05M
2024-12-31$145.49M$219.82M$1.15M-$67.48M-$11M
2023-12-31$128.85M$219.39M$312,000.00-$46.44M$100M-$105.55M
2022-12-31$181.47M$144.47M$172,000.00-$141.83M$6.84M
2021-12-31$34.6M$98.56M$298,000.00-$100.3M$7.42M
2020-12-31-$36.94M-$2.99M$2,000.00-$2M$167,000.00$209.16M
2019-12-31-$151.98M-$75.44M$149,000.00-$127.15M$143.77M